兔骨关节炎模型早期关节软骨及软骨下骨生化改变及二磷酸盐的干预效应(3)
第1页 |
参见附件。
参 考 文 献
[1] Pelletier JP, MartelPelletier J, Howell DS Etiopathogenesis of osteoarthritis A Textbook of Rheumatology,2001, p:2195245 (chapter 110).
[2] Feuerherm AJ, Borset M, Seidel C, et al Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis Scand J Rheumatol, 2001, 30:229234.
[3] Hayami T, Pickarski M, Zhuo Y, et al Characterization Of articular cartilage and subchondral bone changes in the rat anterior cruclate ligament transection and meniscectomized models of osteoarthfitis. Bone,2006,38(2):234243.
[4] 王玉彬,陈安民,郭风劲,等 基质金属蛋白酶家族在骨关节炎软骨组织中表达的研究 中国矫形外科杂志, 2007, 15(11):853855.
[5] 周辉,董刚,夏志敏,等 MMP1、MMP9 mRNA在创伤性骨关节炎软骨中的表达 中国骨质疏松杂志,2009,15(2):9698.
[6] Selingerc I, Day CJ, Morrision NA, et al Optimized transfection of diced siRNA into mature primary human osteoclasts: inhibition of cathepsin k mediated bone resorption by siRNA J Cell Biochem,2005(96):9961002.
[7] Wittrant Y, Couillaud S, Theoleyrd S, et al Osteoprotegerin differentially regulates protease expression in osteoclast cultures J Biochem Biophys Res Commun,2002,293:3844.
[8] 史晓林, 刘康, 吴连国 骨碎补总黄酮对骨质疏松靶标一组织蛋白酶K干预价值的探讨.中国创伤骨科杂志,2008,16(5):7072.
[9] 王运林,刘晓睛,杨菲,等 金雀异黄素抑制IL1α刺激破骨样细胞的组织蛋白酶K表达.中国细胞生物学报, 2006,28:473476.
您现在查看是摘要介绍页,详见PDF附件。